That's crucial, due to the fact that the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error procedure (jeff brown investor prediction). Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. This was a breakthrough nearly nobody observed. However it's going to have extensive implications for treating disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of investment opportunities in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (future report review). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps considerably prior to going higher - jeff brown market predictions. I've been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly educating readers. But that's not the huge concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. melania trump. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are so numerous excellent personal business on the edge of hitting the public markets And I've been dealing with a new method for you to invest even prior to these companies go public.
This opportunity has actually been constructing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to schedule your area totally free.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our typical beat (jeff brown investor prediction). And when it comes to tech investing, we leave it to the specialists. Fortunately, we have several such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing specialists we understand (last year). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and much more. These trends are experiencing rapid growth and creating extraordinary opportunities for investors. I desire to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. jeff brown genetic sequencer stock. However in spite of what many readers may think, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic interrupted supply chains last year, an excellent 250 million 5G-enabled devices were still offered.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (legacy report prediction). Losing two months of production and sales actually impacts how numerous 5G gadgets are offered in the fiscal year. When you think about all of that, offering 250 million units is remarkable. More significantly, the hold-ups triggered by the pandemic produced a lots of bottled-up demand. And that need is now going to be pressed into 2021. In fact, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - democratic republic. Which's not my only 5G prediction When I have actually talked about 5G in the past, I've explained its 3 different phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Phase 3, 5G services begin to be used (social media). That's when we begin to see applications running on 5G networks. Consider things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage Three by this summertime. This begins something of a virtuous cycle: The majority of people don't really care about the technology. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open a suite of incredible applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next crucial innovation I foresee in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a comparable concept however with our genetic code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For years, CRISPR was mainly a specific niche technology that wasn't well understood. And during that time, there were actually only three companies operating in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering amazing returns. This entire market is efficiently a greenfield chance.
There's room for lots of business to exist in this area. jeff brown biotech stock pick for 2020. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that two or three more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software can accurately anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That is very important due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error procedure. But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however several drug treatments produced utilizing this technology. This was one of those breakthroughs that practically no one discovered. But it's going to have extensive implications for treating illness. And, obviously, there will be a lot of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back perhaps substantially prior to going higher. I have actually been covering bitcoin for a long time now. One of the very first research reports I ever published was on bitcoin - jeff brown investment prediction. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my suggestion. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. diplomatic relations. Mass, Mutual is a 150-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the info is up to date since February 2021, but we might not separately validate this claim. Provided Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to choose winning technology stocks. He spent more than 25 years looking into innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an exceptional point of view on the marketplace. He's constantly on the hunt for brand-new chances, and he shares a number of his finest choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he effectively anticipated a few of the most significant financial occasions of the past 20 years. Although he does not appear to launch his picks to the general public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it right each time, however Jeff Brown's precise predictions have actually earned him legions of devoted fans. That states a lot about his ability. The Near Future Report is published by Brownstone Research, a prominent monetary research publisher. Brownstone Research study provides numerous research services with a variety of specializations - biotech stocks jeff brown.
The business is also connected with Bonner & Partners, another well-respected research study publisher - jeff brown stock market prediction. On its site, Brownstone says its mission is to provide retail investors with professional-grade research: "For too long, the very best financial investment research has actually not been readily available to private financiers. It has been usually scheduled for investment banks, hedge funds, personal equity, and high-net-worth clients. brownstone research. The mission of Brownstone Research study is to make that sort of proprietary research available to any financiers seeking to get an edge in the marketplaces. The objective is simple to provide distinct and profitable financial investment research found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise functions as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you understand even a bit about the marketplace, you know that he has a track record as a King Midas of sorts. tech stock. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown believes S.A.V. jeff brown biotech picks. could be "the most significant trend of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding 2 cutting-edge innovations: expert system and electric cars. Musk hopes the combination will help him develop the first fully-autonomous, self-driving cars ever. It's absolutely nothing except the automobile market's Holy Grail. As you understand, electrical lorries and self-driving car stocks have been huge this year, however the Wall Street machine has been big on buzz without much concrete outcome. Despite a drastic boost in competition over the previous couple of years, Brown still thinks Musk has the best possibility of putting it all together.
tech could be the magic string that ties it all together. S.A.V. means Shared Autonomous Car, and it could be the future of transport. Generally, this technology would permit you to rent out your cars and truck as a self-governing, self-driving taxi when you're not utilizing it. You simply leave the cars and truck and press a button on an app that informs the car to "join the fleet." Next thing you understand, you're unwinding on your sofa while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a large portion of the revenues. It sounds outrageous, but it might be closed than you think.